Davis Karedan

SKAN, Wellcome Sanger Institute and University of Newcastle to study early stem cell mutations in rare blood disorder

The research collaboration will extend cutting-edge stem cell genomic analysis to cancer subtypes such as Langerhans Cell Histiocytosis (LCH), an…